clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Seattle Hub for Synthetic Biology Launched with Jay Shendure at the…
News & Features
3D Printing Could Build Tissues within Body
News & Features
Class of Diabetes Drugs May Prevent Development of Colorectal Cancer
News & Features
Map of DDX3X Gene Shows Impacts to the Health of Any…
News & Features
Smear Test Flags Ovarian Cancer
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Microdissection
News & Features
Roche Diagnostics Buys Tissue-Dissection Technology from AvanSci Bio
Clinical OMICs Staff Writer
-
December 10, 2014
0
Related Content
Nasal Swab Test Separates High- from Low-Risk Lung Cancer Polyps
Wireless Pill Can Monitor Vital Signs from Stomach
Mount Sinai Team Identify 4,729 Gene Clusters That Influence Progression of 32 Cancer Types
T-Therapeutics Series A Raises $59M for Development of TCR Cancer Therapies
Inside Precision Medicine
![MilliSect is a mesodissection instrument that enables efficient dissection from slide-mounted tissue for both clinical/research pathology and histology laboratories. [AvanSci Bio]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/172.jpeg "Roche Diagnostics Buys Tissue-Dissection Technology from AvanSci Bio")
